abstract |
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein A, B and R 1 to R 7 are as described below. These compounds are BACE1 and/or BACE2 inhibitors and can be used as medicaments for the therapeutic and/or prophylactic treatment of diseases such as Alzheimer's disease, diabetes, especially type II diabetes, and other metabolic diseases. |